Trial Profile
Questionnaire Survey on the Use of Depot Formulation of Leuprorelin Acetate Injection in Patients with Prostate Cancer (QLIPP)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Oct 2020
Price :
$35
*
At a glance
- Drugs Leuprorelin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms QLIPP
- 02 Oct 2020 Status changed from active, no longer recruiting to completed.
- 01 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 08 May 2018 Status changed from not yet recruiting to recruiting.